Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6.
about
Molecular biology and pathogenicity of mycoplasmasStructure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinisBeta-D-glucoside utilization by Mycoplasma mycoides subsp. mycoides SC: possible involvement in the control of cytotoxicity towards bovine lung cells.Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1alpha (MIP-1alpha), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice.Antigenic and genetic characterization of lipoprotein LppQ from Mycoplasma mycoides subsp. mycoides SC.Lipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-kappaB and activator protein 1.Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.Presence of Lps(d) mutation influences cytokine regulation in vivo by the Mycoplasma arthritidis mitogen superantigen and lethal toxicity in mice infected with M. arthritidis.Isolation and partial purification of macrophage- and dendritic cell-activating components from Mycoplasma arthritidis: association with organism virulence and involvement with Toll-like receptor 2.Mycoplasma agalactiae MAG_5040 is a Mg2+-dependent, sugar-nonspecific SNase recognised by the host humoral response during natural infection.Interactions between mycoplasma lipid-associated membrane proteins and the host cells.Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethalTumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse modelBacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesisMolecular mechanisms of pathogenicity of Mycoplasma mycoides subsp. mycoides SC.Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentrationMycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells.Transcriptional activation of mRNA of intercellular adhesion molecule 1 and induction of its cell surface expression in normal human gingival fibroblasts by Mycoplasma salivarium and Mycoplasma fermentans.Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2.Synergic effects of mycoplasmal lipopeptides and extracellular ATP on activation of macrophages.In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.Mycoplasma hyorhinis molecules that induce tumor necrosis factor alpha secretion by human monocytesMycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide.The importance of B-cells and ecto-5'nucleotidase in Mycoplasma fermentans infection and the relevance to rheumatoid arthritis.Domain analysis of lipoprotein LppQ in Mycoplasma mycoides subsp. mycoides SC.Enhanced biomethane production rate and yield from lignocellulosic ensiled forage ley by in situ anaerobic digestion treatment with endogenous cellulolytic enzymes.
P2860
Q24548575-1167E8FC-FE3B-4B43-8FA7-F17B30C499B8Q32018362-B84F4B74-0A04-49D8-84EE-FB75E62F98B1Q33282318-492C1BB0-13BF-4962-9941-A2E188EAE8EEQ33876738-2DB47289-EFA4-4115-8915-08B8494B9534Q33998478-50471C6C-94E4-44DA-8C77-8E42065AADE4Q34001138-C6F07BCA-88B1-4947-8080-91E0E454BA46Q34002676-6666A773-F26B-485E-9A90-C67D1B50ADC0Q34007822-5F26CA7F-A0A7-49E5-802D-C4CA004CE92FQ34033844-02E859AB-7423-4D28-A31B-585614EC9E25Q34612426-EA966092-9025-43E6-933E-D6FE83E50544Q34619536-65178096-D942-4215-AAEF-964FA8FEFE67Q35164987-D06C4965-D18A-416F-8B5E-61754C0A0D83Q35596295-591DE491-A7B1-450D-8BEA-6FB9B7E2E949Q36671660-20835F23-ADE1-4004-981F-2687E4352661Q36677859-44DE03C7-4709-48DE-ADF4-0C51F67750ABQ36862967-C10B258C-3217-4657-BD75-E99F960CE512Q37099478-63D6F969-B544-4354-8946-535E71C04666Q39510942-A18505D1-B2A4-4BC6-9CCA-69E306478D2FQ39513165-B6236306-413D-4BC6-928D-E93C3EB6E509Q39655361-7B95EF30-2E6F-4F03-89F6-029F10FA3517Q39655369-D1613A35-8D67-4D1C-B0D5-45A7B9A9C91FQ39823145-052888D0-EC68-4E7A-BD5D-7D0B843ABC30Q39824231-D8F2C742-A198-4A34-B9E0-F57EEC919030Q40097612-7FE89445-AA71-4F51-8BC5-88D603D371B5Q41818576-4E4FA84C-AA0E-461B-8FCC-600035BA412DQ42261464-B987C2C1-3953-4CEB-BBC8-1F355052E3F8
P2860
Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Purification and partial bioch ...... sis factor, and interleukin-6.
@ast
Purification and partial bioch ...... sis factor, and interleukin-6.
@en
Purification and partial bioch ...... sis factor, and interleukin-6.
@nl
type
label
Purification and partial bioch ...... sis factor, and interleukin-6.
@ast
Purification and partial bioch ...... sis factor, and interleukin-6.
@en
Purification and partial bioch ...... sis factor, and interleukin-6.
@nl
prefLabel
Purification and partial bioch ...... sis factor, and interleukin-6.
@ast
Purification and partial bioch ...... sis factor, and interleukin-6.
@en
Purification and partial bioch ...... sis factor, and interleukin-6.
@nl
P2860
P1476
Purification and partial bioch ...... sis factor, and interleukin-6.
@en
P2093
P2860
P304
P407
P577
1994-09-01T00:00:00Z